Relieve Genetics' Corporate Minority Round

Relieve Genetics raised a round of funding on April 11, 2016. Investors include Intrexon.

Relieve Genetics is a San Francisco-based biotechnology company focusing on a breakthrough, non-opioid gene therapy approach for neuropathic pain.…

Articles about Relieve Genetics' Corporate Minority Round: